Vyvanse® (lisdexamfetamine) for the Treatment of Binge-Eating Disorder
Vyvanse® is indicated to treat moderate-to-severe binge-eating disorder and attention deficit hyperactivity disorder (ADHD). Credit: Sardaukar Blackfang.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more